"User-testing" as a method for testing the fitness-for-purpose of written medicine information

Patient Education and Counseling

Volumn 83, Issue 3, 2011, Pages 404-410

  Raynor, David Kenneth ^a   Knapp, Peter ^a   Silcock, Jonathon ^b   Parkinson, Brian ^c   Feeney, Karen ^d  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF BRADFORD   (United Kingdom)

^c Making Sense Design   (United Kingdom)

^d LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Anticoagulant; Patient information; Readability; Testing

Indexed keywords

ANTICOAGULANT AGENT; IBUPROFEN;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MEDICAL INFORMATION; MEDICAL INFORMATION SYSTEM; OUTCOME ASSESSMENT; PATIENT INFORMATION; PRIORITY JOURNAL; READING; SEMI STRUCTURED INTERVIEW; UNITED KINGDOM; WRITTEN LANGUAGE;

AGED; ANTICOAGULANTS; COMMUNICATION; COMPREHENSION; CONSUMER HEALTH INFORMATION; FEMALE; GREAT BRITAIN; HUMANS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; PAMPHLETS; PATIENT EDUCATION AS TOPIC; PHARMACISTS; QUESTIONNAIRES; WRITING;

EID: 79958771829     PISSN: 07383991     EISSN: 18735134     Source Type: Journal    
DOI: 10.1016/j.pec.2011.03.016     Document Type: Article

References (25)

1. Raynor D.K., Blenkinsopp A., Knapp P., Grime J., Nicolson D.J., Pollock K., et al. A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines. Health Technol Assess 2007, 11:1-160.
2. Wright P. Designing healthcare advice for the public. Handbook of applied cognition 1999, John Wiley, Chichester. F. Durso (Ed.).
3. Raynor D.K. Testing, testing: the benefits of user testing package leaflets. Regul Aff Focus 2008, 1:16-19.
4. European Commission Council Directive. The labelling of medicinal products for human use and on package leaflets 1992, European Commission, Brussels.
5. Medicines and Healthcare Products Regulatory Agency Always read the leaflet: getting the best information with every medicine. Report of the Committee on Safety of Medicines Working Group on Patient Information 2005, The Stationery Office, London.
6. Sless D., Shrensky R. Writing about medicines for people 2006, Australian Self-Medication Industry, Sydney. 3rd ed.
7. Baglin T.P., Keeling D.M., Watson H.G. Guidelines on oral anticoagulation (warfarin): third edition - 2005 update. Brit J Haematol 2005, 132:277-285.
8. Pirmohamed M., James S., Meakin S., Green C., Scott A.K., Walley T.J., et al. Adverse drug reactions as a cause of admission to hospital. Prospective analysis of 18,820 patients. Brit Med J 2004, 329:15-19.
9. Howard R.L., Avery A.J., Slavenburg S., Royal S., Pipe G., Lucassen P. Which drugs cause preventable admissions to hospital? A systematic review. Brit J Clin Pharmacol 2007, 63:136-147.
10. Baughman C., Spurling L., Mangoni A.A. Provision of warfarin education to hospital inpatients. Brit J Clin Pharmacol 2008, 66:416-417.
11. Food and Drugs Administration. Medication guide: Coumadin [accessed 16.10.09]. http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088578.pdf.
12. National Patient Safety Agency. Actions that can make anticoagulant therapy safer. NPSA Patient Safety Alert, 18. [accessed 16.10.09]. http://www.npsa.nhs.uk/patientsafety/alerts-and-directives/alerts/anticoagulant/.
13. Baglin T.P., Cousins D., Keeling D.M., Perry D.J., Watson H.G. Recommendations from the British Committee for Standards in Haematology and National Patient Safety Agency. Brit J Haematol 2006, 136:26-29.
14. National Patient Safety Agency. Oral anticoagulant therapy booklet. [accessed 16.10.2010]. http://www.nrls.npsa.nhs.uk/EasySiteWeb/getresource.axd%3FAssetID=61788%26type=full%26servicetype=Attachment.
15. Kelly M. The role of theory in qualitative health research. Fam Pract 2010, 27:285-290.
16. Raynor D.K., Dickinson D. Key principles to guide development of consumer medicines information. Ann Pharmacother 2009, 43:700-706.
17. Raynor D.K., Knapp P. Improving patient information - where do we go from here?. RAJ Pharma 2008, 1:657-661.
18. Raynor D.K. Medication literacy is a 2-way street. Mayo Clin Proc 2008, 83:520-522.
19. Fang F.C., Machtinger E.L., Wang F., Schillinger D. Health literacy and anticoagulation-related outcomes among patients taking warfarin. J Gen Intern Med 2006, 21:841-846.
20. Sless D. Measuring information design. Inf Des J 2008, 16:250-258.
21. Knapp P., Raynor D.K., Silcock J., Parkinson B. Performance-based readability testing of participant information for a Phase 3 IVF trial. Trials 2009, 10:79.
22. Knapp P., Raynor D.K., Silcock J., Parkinson B. Performance-based readability testing of participant materials for a phase I trial: TGN1412. J Med Ethics 2009, 35:573-578.
23. Narhi U. Drug information for consumers and patients - a review of research. 2006, Publications of National Agency for Medicines, Finland.
24. Raynor D.K. Addressing medication literacy: a pharmacy practice priority. Int J Pharm Pract 2009, 17:257-259.
25. Hirsh D., Clerehan R., Staples M., Osborne R.H., Buchbinder R. Patient assessment of medication information leaflets and validation of the Evaluative Linguistic Framework (ELF). Patient Educ Couns 2009, 77:248-254.